Keefe, Bruyette & Woods Increases CME Group (NASDAQ:CME) Price Target to $226.00

CME Group (NASDAQ:CME) had its price objective hoisted by equities research analysts at Keefe, Bruyette & Woods from $222.00 to $226.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “market perform” rating on the financial services provider’s stock. Keefe, Bruyette & Woods’ target price indicates a potential upside of 7.14% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Morgan Stanley boosted their price objective on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a research note on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $210.00 target price (down from $235.00) on shares of CME Group in a report on Friday, April 5th. Rosenblatt Securities reissued a “sell” rating and set a $187.00 price target (up previously from $185.00) on shares of CME Group in a research report on Thursday. Finally, Barclays boosted their target price on CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a report on Monday, April 8th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $217.80.

CME Group Trading Down 0.8 %

NASDAQ CME opened at $210.94 on Thursday. CME Group has a 12 month low of $175.73 and a 12 month high of $223.80. The stock has a 50-day simple moving average of $214.73 and a 200 day simple moving average of $211.90. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $75.94 billion, a PE ratio of 24.00, a P/E/G ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the prior year, the business posted $2.42 EPS. CME Group’s revenue was up 3.2% on a year-over-year basis. Research analysts forecast that CME Group will post 9.58 EPS for the current year.

Institutional Trading of CME Group

A number of institutional investors have recently bought and sold shares of the business. B. Riley Wealth Advisors Inc. grew its position in CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after buying an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC boosted its position in shares of CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after acquiring an additional 48 shares in the last quarter. Lantz Financial LLC increased its stake in CME Group by 1.1% in the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after acquiring an additional 49 shares during the last quarter. Transcend Capital Advisors LLC boosted its holdings in shares of CME Group by 1.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock valued at $631,000 after purchasing an additional 50 shares in the last quarter. Finally, Jaffetilchin Investment Partners LLC boosted its holdings in shares of CME Group by 1.7% in the 3rd quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider’s stock valued at $605,000 after purchasing an additional 51 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.